Build a Clinical Trial Consent Package

Create a review-ready training consent package for a fictional U.S. drug trial.

Introduction

30 Second Summary

Joining a medical study can involve unfamiliar procedures, uncertain benefits, and risks that are hard to weigh under pressure. A clear conversation gives each person the space to decide what fits their life.

In this project, you will create a review-ready training informed consent package in Microsoft Word for fictional protocol TRN-101. You will also write an everyday-language explanation that supports a voluntary decision.

What You'll Build

Picture yourself presenting a training package that helps a participant understand the choice while giving an IRB reviewer a clear map of every major disclosure.

By the end of this project, you'll have:

A participant-facing training consent form that lets someone quickly understand why they might or might not join fictional protocol TRN-101.
A regulatory crosswalk that lets you trace each major disclosure to FDA rules, the Common Rule, IRB responsibilities, or Good Clinical Practice provisions.
A plain-language talk track that lets you explain the study's purpose, activities, risks, alternatives, privacy protections, uncertain benefit, and voluntary nature without pressure.
Secret Mission: Add a neutral teach-back check that reveals which parts of your explanation need clearer wording.

Are there any prerequisites?

You need Microsoft Word installed on Windows with an existing license. The project explains the regulatory mapping, so basic familiarity with clinical trial terminology is only helpful.

Before We Start

A consent form supports an ethical decision when its purpose is clear from the start. This checkpoint defines the audience before you begin drafting.

Set Up the Controlled Document

An informed consent draft without a clear identity can be mistaken for an approved enrollment document. A missing training warning creates the same risk.

Document control gives the draft a traceable identity. Microsoft Word will hold the protocol identifier, planned structure, training warning, version details, and page numbers.

In this step, get ready to:

Create a saved training document with a clear protocol identity and training-use warning.
Add the planned sections for the complete consent package.
Add a controlled footer with the protocol identifier, version, date, and page numbers.

Create the Training Document

The title block tells a reviewer which fictional study the document belongs to. The warning keeps the draft clearly separated from an approved consent form.

Press the Windows key to open the search bar.
Type Microsoft Word into the search bar.
Press Enter to open Microsoft Word.
Select File in the top left corner.
Select New.
Select Blank document.

You should see an empty document with the cursor ready at the top of the first page.

Enter a three-line title block using these values:

TRN-101.
Study Drug A.
Site: site placeholder.

Type Training Example Only: Not IRB Approved and Not for Participant Enrollment beneath the title block.

The first save asks you to choose a folder and file name. The .docx file becomes the working copy that you update throughout the project.

Save the document as Training_ICF_v0.1.docx.

Good progress. The Word title bar should now show Training_ICF_v0.1.docx. Your first page should identify the fictional study as a training example.

Why Document Control Matters

The protocol identifier connects the document to fictional study TRN-101. Version 0.1 identifies the current draft.

The training warning prevents this exercise from looking like an approved form for real enrollment. A real consent form needs reconciliation with the actual protocol and the reviewing IRB's requirements.

Add the Planned Sections

The planned headings create a map for the disclosures and review materials you add later. Their order moves from the participant's immediate decision to documentation and quality review.

Place the cursor beneath the training warning.
Add each of these planned sections on its own line:

Key Information.
Why Is This Study Being Done?.
What Will Happen?.
Risks and Discomforts.
Possible Benefits.
Alternatives.
Privacy and Records.
Costs and Payment.
Research-Related Injury.
New Information.
Leaving the Study.
Contacts.
Voluntary Participation.
Future Use of Information and Samples.
Signatures.
Regulatory Crosswalk.
Quality Review.
How I Would Explain This Consent to a Participant.

Save Training_ICF_v0.1.docx.
Scroll from Key Information to How I Would Explain This Consent to a Participant.

That structure is now in place. You should see every planned section in the same order as the list above.

Missing or Repeated Headings?

Compare the document with the list above from top to bottom. Add any missing heading at its planned position.

Delete any accidental duplicate before you continue. Help me compare my consent-package headings with the required list.

Add the Controlled Footer

A footer keeps the protocol identity and draft version visible when pages are printed or separated. Page numbers make review comments easier to trace to the correct location.

Double-click the footer area at the bottom of the page.
Type Protocol TRN-101 | Version 0.1 | 08 Sep 2026 followed by a space.

You should see the protocol identifier, version, and date inside the footer area.

Select Insert in the Word ribbon.
Select Page Number.

Word should display the available page-number placement options.

Select Current Position.
Choose a plain page-number style.

You should see a page number beside the controlled footer text.

Select Close Header and Footer.
Save Training_ICF_v0.1.docx.

Before you check the finished document, which details do you expect to prove that this draft is controlled and safe for training use?

Return to the first page of Training_ICF_v0.1.docx.
Scroll from the title block through the final planned heading.
Check the footer on a later page.

You should see the fictional protocol identifier above the training warning. Every planned heading should appear in the document.

The footer should read Protocol TRN-101 | Version 0.1 | 08 Sep 2026. A page number should appear beside it.

Footer or Page Number Missing?

Footer text that moves with the document body was entered outside the footer area. Re-enter it after double-clicking the bottom of the page.

A missing page number usually means no style was selected. Repeat the Page Number steps above.

Help me fix the footer or page numbering in Word.

Your controlled training document now has a clear identity, a complete section map, and traceable page details. Next up, you will draft the Key Information section and expose the disclosures that still need detail.

Draft Key Information

Your controlled Microsoft Word document already signals its identity and training status. The next challenge is helping a prospective participant understand the decision quickly.

The Key Information section brings the most decision-relevant facts to the front of the informed consent process. You will draft that opening before testing how much of the participant's decision it can support.

In this step, get ready to:

Draft a concise overview of the study choice.
Present a balanced decision summary.
Run a gap check against the empty detailed sections.

Draft the study overview

The Key Information heading in the document from earlier is your drafting point. Participant-facing language should explain the choice without assuming that the reader knows clinical trial terminology.

Write an opening sentence stating that this is research on Study Drug A for migraine prevention in adults.
Add a sentence explaining that participants are assigned by chance in a 1:1 ratio to Study Drug A or placebo.

You should now see the study purpose followed by the treatment assignment. A participant can use these sentences to identify the central choice.

Add a sentence explaining double blinding in participant-friendly language. State that the participant and study team do not know which assignment the participant receives during the study.
Add a schedule paragraph covering the 16-week duration. Include six visits. Include daily electronic diary entries. Include study tablets. Include blood draws.

The overview should now show what participation involves. The six visits plus daily diary entries make the main time burden visible.

Close the overview by stating that participation is voluntary.

Your opening now identifies the research purpose, treatment assignment, study duration, study tasks, time burden, and participant choice.

What does 1:1 assignment mean?

A 1:1 assignment gives each participant an equal chance of receiving Study Drug A or placebo. Assignment by chance prevents the participant or study team from choosing the group.

Double blinding keeps the assignment hidden from the participant and study team during the study. Plain language helps the reader understand how those two features affect their experience.

Balance the decision

A useful opening presents reasons someone might join alongside reasons they might decline. Balanced wording keeps uncertain benefit from sounding like a promise.

Add a sentence stating that the participant may or may not benefit from taking part.
Write one risk paragraph covering these training-only foreseeable risks: nausea, dizziness, skin rash, blood-draw pain or bruising, privacy loss, and unknown risks.

You should now see uncertain benefit beside the possible harms. This placement gives both sides of the decision comparable weight.

Add an alternative stating that the person can choose not to join.
State that the person can discuss usual-care options with their treating clinician.

Before you read the section aloud, which point do you expect to sound least clear to someone hearing about the study for the first time?

Read the complete Key Information section aloud at a natural pace.

You should finish in about two minutes. A listener should hear that this is research, what participation involves, what could go wrong, why benefit is uncertain, what alternatives exist, and who controls the choice.

Why does balance matter?

Balanced risk communication gives possible benefits the same careful treatment as foreseeable harms. Words such as may or may not preserve uncertainty without hiding the study's purpose.

The alternative belongs in the same decision summary. A participant needs to know that usual care remains available outside the study.

Expose the remaining gaps

The opening now sounds coherent when read on its own. The untouched headings provide a direct test of whether that short summary can carry the whole consent package.

Before you compare the sections, do you think the opening contains enough detail to support every part of an informed decision?

Scroll from Key Information through Signatures to identify the sections that remain empty.
Compare the opening with Privacy and Records, Research-Related Injury, Contacts, Leaving the Study, and Signatures.

You should find that those detailed sections remain empty. This is the intended shortfall: the opening supports orientation without supplying the full disclosures, documentation, or consent discussion.

Why is the gap intentional?

The concise opening helps a participant identify the main decision. Detailed sections still need to explain privacy protections, injury information, contact routes, withdrawal consequences, and signature documentation.

Making those gaps visible prevents a readable summary from being mistaken for a complete consent form.

Type DETAIL REQUIRED beneath every empty participant-facing heading from Why Is This Study Being Done? through Future Use of Information and Samples.
Type DETAIL REQUIRED beneath Signatures.

You should now see a visible marker beneath every detailed section that still needs content. The document makes its unfinished areas explicit.

Record the first gap check beneath Quality Review. State that a readable opening does not replace full disclosures, documentation, or the consent discussion.
Save Training_ICF_v0.1.docx.

Before your final review, which features do you expect to distinguish the concise opening from the unfinished detailed sections?

Read the Key Information section aloud once more.
Continue scrolling through Signatures to check for a marker beneath every unfinished detailed heading.

You should finish the opening in about two minutes. You should then see DETAIL REQUIRED beneath the unfinished details plus a recorded first gap check under Quality Review.

That is a valuable checkpoint: participants can now grasp the main choice while every missing detail remains visible. Next, you will turn those gaps into complete disclosures and a regulatory crosswalk.

Complete the Consent and Crosswalk

Your Key Information section now makes the central choice visible to a prospective participant. The DETAIL REQUIRED markers expose the disclosures that remain.

Full informed consent gives the participant enough detail to weigh the study. A regulatory crosswalk lets an IRB reviewer trace every duty to a specific location.

In this step, get ready to:

Replace every detailed disclosure marker with participant-facing content.
Insert the required ClinicalTrials.gov statement exactly as provided.
Build a regulatory crosswalk with no blank required rows.

Complete the detailed participant sections

The opening summary helps a participant understand the main choice. The detailed sections support that choice with the full study information.

In the open Training_ICF_v0.1.docx in Microsoft Word, replace DETAIL REQUIRED under Why Is This Study Being Done?. Explain that this fictional study tests whether Study Drug A may help prevent migraines. State that approximately 120 adults are expected to join.
Replace DETAIL REQUIRED under What Will Happen?. Describe the 1:1 random assignment to Study Drug A or placebo. Explain the double blinding. Include the 16-week duration. Include six visits. Include daily electronic diary entries. Include study tablets. Include blood draws.

Good progress. The study purpose and participant workload now sit under dedicated headings.

Replace DETAIL REQUIRED under Risks and Discomforts. Describe nausea. Describe dizziness. Describe skin rash. Describe blood-draw pain or bruising. Describe possible privacy loss. State that unknown risks may exist.
Replace DETAIL REQUIRED under Possible Benefits. State that the participant may benefit. Make clear that benefit is uncertain. Avoid promising an improvement in migraines.

You should now see a balanced account of possible harm and uncertain benefit. That balance supports a voluntary decision.

Replace DETAIL REQUIRED under Alternatives. Explain that the participant may choose not to join. Direct the participant to discuss usual-care options with their treating clinician.
Replace DETAIL REQUIRED under Privacy and Records. Explain that the study team takes steps to protect research records. State that privacy cannot be guaranteed completely. State that authorized representatives of the FDA may inspect study records as permitted by law.

The detailed body now covers the choice outside the study and the limits of research privacy. A participant can see both before deciding.

Replace DETAIL REQUIRED under Costs and Payment. Insert SITE-SPECIFIC COST LANGUAGE REQUIRED for participant costs. Insert PAYMENT AMOUNT AND SCHEDULE REQUIRED for payment details.
Replace DETAIL REQUIRED under Research-Related Injury. Insert INSTITUTION-SPECIFIC INJURY LANGUAGE REQUIRED so the training draft does not invent a site policy.

You should now see clear placeholders where real institutional terms must be reconciled before operational use. The training warning keeps those unresolved details visible.

Replace DETAIL REQUIRED under Contacts. Insert STUDY CONTACT DETAILS REQUIRED for study questions or injury concerns. Insert PARTICIPANT-RIGHTS CONTACT DETAILS REQUIRED for questions about participant rights.
Replace DETAIL REQUIRED under New Information. State that significant new findings that may affect willingness to continue are shared during the study.

The draft now shows where participants can ask different kinds of questions. It also explains how relevant new findings reach them.

Replace DETAIL REQUIRED under Leaving the Study. Explain that the participant can stop at any time. Describe that orderly withdrawal steps may be needed for safety. State that the investigator may end participation for safety concerns or failure to follow study instructions.
Replace DETAIL REQUIRED under Voluntary Participation. State that joining is voluntary. Explain that refusing causes no penalty or loss of entitled benefits. Explain that leaving later causes no penalty or loss of entitled benefits.

You should now see the participant's choices before enrollment and during the study. The withdrawal language also explains how participation may end safely.

Replace DETAIL REQUIRED under Future Use of Information and Samples. State that samples are used only for the study tests listed in the consent. State that information or samples are not stored or distributed for future research. State that they are not used for commercial profit. State that they do not undergo whole genome sequencing. State that clinically relevant routine safety results are discussed as specified by the fictional protocol.
Save Training_ICF_v0.1.docx.

The participant-facing body now covers the full fictional study decision. Every former detail marker either contains a disclosure or an explicit site-specific placeholder.

Still Finding Detail Markers?

Search the document for DETAIL REQUIRED. Replace any remaining marker under the participant-facing headings covered above.

Keep the site-specific cost, payment, injury, and contact placeholders visible. Help me identify which participant-facing disclosures are still missing from my fictional consent draft.

Insert the required trial registration statement

This fictional study is treated as an applicable clinical trial. Its ClinicalTrials.gov disclosure must be reproduced word-for-word.

Under Why Is This Study Being Done?, add this standalone paragraph exactly as written: A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time.
Compare the inserted paragraph with the provided wording one character at a time. Keep http://www.ClinicalTrials.gov unchanged.

You should see the complete statement as one participant-facing paragraph. Its capitalization and web address should match the provided text exactly.

Why Must This Wording Match?

The FDA requires this statement to be reproduced word-for-word for an applicable clinical trial. Preserving the supplied wording protects the regulatory meaning.

The statement also explains what the public record can contain. It tells participants that identifying information is excluded.

Build the regulatory crosswalk

A crosswalk connects each disclosure duty to evidence in the document. It brings the FDA requirements, the Common Rule, and FDA E6(R3) into one review path.

Under Regulatory Crosswalk, replace DETAIL REQUIRED with an 11-row table that has four columns.
Enter Source, Requirement, Consent Location, and Status across the header row.

You should now see one header row with space for ten regulatory mappings. Each remaining row represents one source from the review plan.

Complete the row for 21 CFR 50.20. Summarize sufficient decision time, minimized coercion, understandable language, and no exculpatory language. Point to Key Information, Voluntary Participation, and the participant-facing body. Set the status to Addressed in draft.
Complete the row for 21 CFR 50.25. Summarize the basic consent elements, the applicable additional elements, and the required ClinicalTrials.gov statement. Point to the detailed participant sections and the registration paragraph. Set the status to Addressed in draft.

The first two rows should now trace the general consent conditions and participant disclosures. Neither row should rely on Key Information alone.

Complete the row for 21 CFR 50.27. Summarize the IRB-approved written form, signature, date, and participant-copy requirements. Point to Signatures. Set the status to Pending documentation review.
Complete the row for 21 CFR 56.109. Summarize IRB authority to approve, require changes, or disapprove covered research. Point to the training-use warning and the complete draft. Set the status to Training draft. IRB approval required before use..

These rows distinguish drafted consent content from operational approval and documentation. The status column keeps that boundary visible.

Complete the row for 45 CFR 46.116. Summarize Key Information, the full consent elements, the opportunity for discussion, and the selected no-future-use approach. Point to Key Information, the detailed participant sections, and Future Use of Information and Samples. Set the status to Addressed in draft.
Complete the row for 45 CFR 46.117. Summarize the written form, signature, and copy requirements. Point to Signatures. Set the status to Pending documentation review.

The Common Rule rows should now connect the concise opening to the complete body. They should also identify the future-use choice and upcoming documentation controls.

Complete the FDA E6(R3) row for 2.8.1. Summarize documented ethics review approval before enrollment and the expectation for clear information. Point to the training-use warning and the complete participant-facing draft. Set the status to Training draft. IRB approval required before use..
Complete the FDA E6(R3) row for 2.8.7. Summarize the applicable signature and date expectations. Point to Signatures. Set the status to Pending documentation review.

The first two FDA E6(R3) rows now show the difference between understandable materials and documented consent. Both are needed before real enrollment.

Complete the FDA E6(R3) row for 2.8.10. Summarize purpose, research features, study products, random assignment, procedures, risks, possible benefits, alternatives, and injury information. Point to the detailed participant-facing sections. Set the status to Addressed in draft.
Complete the FDA E6(R3) row for 2.8.11. Summarize the participant's receipt of a signed form and updated consent materials. Point to Signatures. Set the status to Pending documentation review.

Before you start the final crosswalk check, do you expect any required row to remain blank?

Test the crosswalk by using every Consent Location entry to point to the exact heading or paragraph in Training_ICF_v0.1.docx.

You should be able to trace all ten sources to a specific location. No required source, requirement, consent location, or status cell should remain blank.

Save Training_ICF_v0.1.docx with the completed participant-facing body and crosswalk.

Crosswalk Location Too Vague?

Replace broad locations such as entire document with the exact heading that contains the evidence. Use more than one heading when a requirement spans several sections.

Keep documentation rows mapped to Signatures with a pending status. Help me make my regulatory crosswalk locations more precise.

Your fictional consent now contains the disclosures needed for a defensible participant decision. Next, you will add the signatures, participant-copy instructions, and quality controls that make the package review-ready.

Document Consent and Review Quality

Your consent draft now contains the detailed disclosures. Its regulatory crosswalk maps every required source to a location.

Complete disclosures can still fail operationally when consent documentation is incomplete. Weak version control can also make the wrong document look current.

This step closes those gaps in Microsoft Word. You will finish with a quality-reviewed Word file plus an inspectable PDF copy.

In this step, get ready to:

Document signature responsibilities.
Confirm participant-copy requirements.
Produce a reviewed PDF copy.

Add signature and conditional role fields

Signature fields document who made the decision. They also identify the person who led the consent discussion.

An IRB-approved plan determines whether a legally authorized representative or impartial witness belongs in the process.

Return to the Signatures section in Training_ICF_v0.1.docx.
Add a participant name field.
Add a participant signature field.
Add a participant date field.
Add a participant time field.
Add a person obtaining consent signature field.
Add a person obtaining consent date field.
Add a person obtaining consent time field.

What do signatures document?

A signature documents the agreement reached through the informed consent process. The surrounding fields connect that agreement to the people involved.

The date and time establish when the agreement was documented. The person obtaining consent field identifies who conducted the discussion.

Add a legally authorized representative signature field.
Place Use only if applicable and IRB approved above that field.
Add an impartial-witness signature field.
Place Use only if applicable and IRB approved above that field.
Save Training_ICF_v0.1.docx.
Review the completed Signatures section from top to bottom.

That accountability trail is now in place. You should see the participant fields plus the person obtaining consent fields.

The legally authorized representative field and impartial-witness field should each carry the conditional-use label.

Document participant copies and version control

A signed copy gives the participant an enduring record of the information they considered. Updated materials keep that record current during participation.

The versioned footer ties every page to the same protocol document. Page numbering makes missing or mixed pages easier to spot.

Add an instruction under the Signatures section stating that the participant receives a copy of the signed and dated form.
Add a second instruction stating that the participant receives updated consent materials during participation.
Save Training_ICF_v0.1.docx.
Scroll through every page of the document.
Check every page for the footer Protocol TRN-101 | Version 0.1 | 08 Sep 2026.
Check every page for a visible page number.

Good progress. The participant-copy instructions now extend the consent record beyond the signature page.

Every page should show the same protocol identifier and version. Each page should also carry its page number.

Run the quality review and export the PDF

A quality review turns an apparently finished form into a documented check. It records the communication risks that were examined before export.

What should the review test?

The table should cover each area that could weaken a participant's decision or an evaluator's confidence:

Understandable language.
A clear distinction between research and clinical care.
Balanced risks and possible benefits.
Realistic alternatives.
Privacy.
Voluntariness.
No pressure.
No exculpatory language.
Unresolved placeholders.
Internal consistency.
Crosswalk completeness.

The exculpatory-language check confirms that the form does not ask participants to waive legal rights. It also confirms that the form does not release anyone from negligence liability.

Return to the Quality Review heading.
Use Word's table tool to add one row for every review check listed above.

You should see a Quality Review table containing all 11 checks.

Evaluate every check against the full consent package.
Record your finding beside each check.

The table now shows what you reviewed. It also makes any remaining gap visible.

Mark each unresolved placeholder as an outstanding training item.
Correct any inconsistent or misleading wording that your review finds.
Recheck each corrected passage against its Quality Review row.

Every Quality Review row should now contain a recorded result. Any unresolved placeholder should remain clearly identified.

Save the finalized Training_ICF_v0.1.docx.

The editable training consent package is now finalized at version 0.1.

A PDF copy gives you a fixed-format review artifact. Saving it from the finalized Word document keeps both files aligned.

Select File in Word.
Select Save a Copy.
Select Browse.
Keep the folder that contains Training_ICF_v0.1.docx.
Select PDF as the file type.
Enter Training_ICF_v0.1.pdf as the filename.
Select Save.

You should now have Training_ICF_v0.1.docx plus Training_ICF_v0.1.pdf in the same folder.

Before you inspect the export, consider which part is most likely to shift during conversion.

Use the Windows file browser to return to the folder containing Training_ICF_v0.1.docx.
Double-click Training_ICF_v0.1.pdf.
Inspect the first page for readable text and the training-use warning.
Inspect every page for the footer Protocol TRN-101 | Version 0.1 | 08 Sep 2026.
Inspect every page for a visible page number.
Inspect the signature page for all required fields.
Inspect the Quality Review table for complete rows.

You should see a readable first page with the training-use warning.

Every page should show the versioned footer plus its page number.

The signature page should contain the participant fields plus the person obtaining consent fields. It should also contain the conditionally labeled representative and witness fields.

The Quality Review table should remain readable in the PDF.

You have completed the operational check. The Word source and PDF copy now present the same controlled training package.

Does the PDF look incomplete?

Repeat the Save a Copy process in Word if the PDF file is missing.
Correct the footer in the Word document if any page lacks the protocol identifier or version.
Adjust page breaks in the Word document if the signature fields or Quality Review table split awkwardly.
Save both files again after making a correction.

Ask for help with the export if the layout still changes.

Your controlled package now documents consent responsibilities and quality checks. Next, you will turn the form into a respectful participant conversation.

Explain the Consent in Plain Language

Your controlled package in Microsoft Word now has signature fields, participant-copy instructions, version control, and a completed quality review. That is the documentation foundation for a review-ready training package.

A signature records a decision. Informed consent is a process that depends on a respectful two-way conversation supporting understanding and voluntary choice.

In this step, get ready to:

Draft a two-to-three-minute participant talk track.
Connect your communication choices to three ethical principles.
Test the completed explanation aloud for clarity and timing.

Draft the participant talk track

A short talk track turns the full consent into a conversation a participant can follow. It must preserve the balanced facts from the form while making the decision easier to understand.

Return to the How I Would Explain This Consent to a Participant heading in the Word document from earlier.

You should see the planned heading below the completed quality review material.

Place your cursor on the blank line below the heading.
Type this opening exactly: I want to explain this study in everyday language. This is research, not your regular medical care, and joining is completely your choice.
Read the opening aloud.

You should hear a clear distinction between research and regular medical care. The final phrase protects voluntary choice from the first moment.

Add one sentence explaining that the study tests whether Study Drug A may help prevent migraines in adults.
Add one sentence explaining that randomization assigns each participant 1:1 to Study Drug A or a placebo under double blinding.
Read both sentences aloud.

The purpose and treatment assignment should sound factual. Both sentences should keep the possible benefit uncertain.

Add one sentence describing the 16-week commitment with six visits.
Add one sentence describing the study tablets, daily electronic diary, and blood draws.
Read this part aloud.

A listener should be able to picture the time commitment. They should also understand the main study tasks.

Add one sentence naming nausea, dizziness, skin rash, blood-draw pain or bruising, privacy loss, and unknown risks.
Add one sentence stating that the participant may or may not benefit.
Read the risk and benefit sentences aloud.

The risks should sound concrete. The possible benefit should remain uncertain.

Add one sentence explaining that the participant can decline participation and discuss usual-care options with the treating clinician.
Add one sentence explaining how study records are protected and who may review them.
Read these sentences aloud.

The alternative should sound realistic. The privacy explanation should match the completed consent.

Add one sentence pointing to the cost and payment details in the consent.
Add one sentence pointing to the research-related injury information and contacts.
Read these sentences aloud.

A listener should know where to find the practical details that could affect their decision.

End the main talk track with one sentence explaining the participant's right to stop at any time.
Read the complete talk track aloud at a natural pace.

Your talk track should take about two to three minutes. You now have a participant-facing explanation that covers the full decision without reading every section of the form.

Does the talk track sound dense?

Shorten any sentence that forces you to pause in the middle to recover your place.
Explain technical terms such as placebo or randomization in everyday language when you first use them.
Compare each statement with the finalized consent so the explanation preserves the same facts.

Ask for help with simplifying the talk track without losing required information.

Connect the explanation to ethics

The ethics paragraph shows why each communication choice protects the participant. It connects your wording to the principles behind informed consent.

How ethics shapes the explanation

Respect for Persons appears through genuine choice, time to decide, opportunities for questions, and checks for comprehension.
Beneficence appears through a balanced account of risks and possible benefits without overpromising.
Justice appears through the same respectful and understandable explanation for every eligible participant.

Place your cursor below the completed talk track.
Type the heading Ethics Behind My Explanation.

You should see a separate heading that clearly distinguishes ethical reasoning from the participant talk track.

Write one sentence linking Respect for Persons to choice, time, questions, and comprehension.
Write one sentence linking Beneficence to balanced risks and possible benefits without overpromising.
Read both sentences aloud.

Each sentence should explain a communication behavior. The principle should connect directly to something you would do during consent.

Write one sentence linking Justice to the same respectful and understandable explanation for every eligible participant.
Read the completed ethics paragraph aloud.

The paragraph should show ethical reasoning through specific communication choices. Each principle should have a distinct role.

Close with neutral prompts

Neutral closing prompts keep the participant in control of the decision. They create space for questions, reflection, and clarification without steering the person toward enrollment.

Add a prompt inviting the participant to ask questions.
Add a prompt offering time to discuss participation with trusted people.
Read both prompts aloud.

The prompts should make time and questions feel expected. Their wording should leave the decision open.

Add a statement confirming that refusing does not reduce medical care or entitled benefits.
Close with a question asking what the participant would like clarified before making a decision.
Read the closing aloud.

The final question should invite the participant to identify what remains unclear. It should avoid language that assumes they plan to join.

Save Training_ICF_v0.1.docx.

The existing Training_ICF_v0.1.pdf remains your pre-explanation checkpoint. This step updates only the open Word document.

Before you deliver the explanation, do you think a listener can understand the main decision without hearing the full consent form?

Deliver the talk track aloud without reading from the full consent form.

At a natural pace, you should finish in about two to three minutes.

What should the listener hear?

The study is research.
Participation is voluntary.
Randomization determines assignment to Study Drug A or placebo.
Double blinding limits who knows the assignment during the study.
The study involves a 16-week commitment with six visits and defined study tasks.
The main risks are clear and the possible benefit remains uncertain.
Usual-care options remain available as an alternative.
Privacy, costs, injury contacts, and the right to stop are addressed.

That is the communication layer complete. Your training package now demonstrates how a controlled consent document supports a respectful participant conversation.

Secret mission

Add a Teach-Back Comprehension Check

A participant can say they understand while still feeling unsure about the study. In this secret mission, you will add three neutral teach-back prompts, an unscored response guide, and a repair process that checks whether your explanation was clear.

Clean Up Your Resources

Your training package lives entirely in two local files with no ongoing cost. Choose whether to keep working, close it for later, or delete both files.

Resources you used:

The editable Microsoft Word document Training_ICF_v0.1.docx, which contains the complete consent package with the plain-language explanation and teach-back check.
The exported Training_ICF_v0.1.pdf PDF, which is an earlier snapshot created before the plain-language explanation and teach-back check were added.

Keep everything running

No action is needed if the current files meet your needs. Choose this if you want to keep refining the training package.

Your PDF Is an Earlier Snapshot

The current Word document includes the plain-language explanation and teach-back check. The existing PDF was exported before those additions.

Refreshing the PDF keeps both formats aligned for future review.

Start an updated PDF export from the open Word document by selecting File.
Select Save a Copy.
Select Browse.
Choose PDF as the file type.
Enter Training_ICF_v0.1.pdf as the filename.
Select Save.
Confirm the replacement if Word asks about the existing file.

Your package is now consistent across both formats. The Word document and PDF both include the final explanation and teach-back content.

Pause - I'll come back to this later

Close the editing session to step away while keeping both files available. You can return without rebuilding any part of the package.

Save the latest changes in Training_ICF_v0.1.docx.
Close Microsoft Word.
Leave Training_ICF_v0.1.docx in its saved location.
Leave Training_ICF_v0.1.pdf in its saved location.

Your editable training package remains ready for your next session. The existing PDF remains an earlier snapshot until you export it again.

Delete - I don't want to use this again

Deleting both files removes the only local copies described in this project. The removal becomes permanent after you clear them from the system's deleted-file storage.

Close Microsoft Word.
Delete Training_ICF_v0.1.docx from the folder where you saved it.
Delete Training_ICF_v0.1.pdf from the same folder.
Permanently remove both deleted files using Windows' recycle feature.
Search Windows for both filenames after cleanup.

You should find no local copies of either file. That's the cleanup complete: both training-package files are now removed.

Nice Work!

You did it! You built a controlled training consent package in Microsoft Word for fictional protocol TRN-101.

What you learned:

Created participant-focused Key Information that helps an adult consider the study choice quickly. Completed the detailed informed consent disclosures needed for a voluntary decision.
Built a Regulatory Crosswalk that links each major disclosure to its source. Added signatures plus participant-copy instructions. Added version 0.1 document controls. Saved Training_ICF_v0.1.pdf with the consent body plus the Quality Review table.
Wrote a plain-language talk track that explains the study without pressure or promised benefit. Connected your communication choices to Respect for Persons. Applied Beneficence through balanced risk communication. Applied Justice through a consistently respectful explanation.
Secret Mission: Added a neutral teach-back comprehension check with three participant-voice prompts. Created response guidance without scoring or enrollment-focused coaching. Built a repair process that checks understanding again before any signature.

Ready to quiz yourself?